Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Head-to-Head Comparison

Design Albumin-binding via DAC → long-acting GHRH analog Short-acting GHRH(1-29) analog without albumin binding Half-life / Exposure Prolonged exposure (days) with sustained GH/IGF-1 rise in humans1 Minutes; brief spikes in plasma → transient GH pulses GH Secr

This comparison does not assign a generated winner or score.

  • Design
  • Albumin-binding via DAC → long-acting GHRH analog
  • Short-acting GHRH(1-29) analog without albumin binding
  • Half-life / Exposure
  • Prolonged exposure (days) with sustained GH/IGF-1 rise in humans1
  • Minutes; brief spikes in plasma → transient GH pulses
  • GH Secretion Pattern
  • Elevates basal GH and augments pulses, trending toward a more tonic profile under continuous exposure1
  • Primarily pulsatile bursts when dosed intermittently, aligning with physiologic ultradian GH rhythms2
  • Physiologic Relevance
  • Useful for sustained stimulation; may blunt relative pulse amplitude depending on background somatostatin tone
  • Better preserves timing-dependent physiology and receptor recovery windows described for normal GH neuroendocrine control2
  • Downstream Readouts
  • Clear increases in circulating IGF-1 over days to weeks in early clinical studies1
  • Short-window GH/IGF-1 excursions; magnitude depends on dose timing and co-secretagogues